AH Equity Partners LSV II’s Nautilus Biotechnolgy NAUT Stock Holding History

AH Equity Partners LSV II’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$4.28M	Hold	1,355,911	–	–	4.48%	3
2023 Q2	$5.25M	Hold	1,355,911	–	–	5.44%	3
2023 Q1	$3.76M	Hold	1,355,911	–	–	4.03%	3
2022 Q4	$2.44M	Hold	1,355,911	–	–	2.97%	3
2022 Q3	$2.88M	Hold	1,355,911	–	–	2.57%	3
2022 Q2	$3.65M	Hold	1,355,911	–	–	3.82%	3
2022 Q1	$5.88M	Hold	1,355,911	–	–	4.24%	3
2021 Q4	$1.36M	Buy	+1,355,911	New	+$7.26M	0.74%	4

Other funds holding NAUT

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return

MVG

Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

ACI

Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return

ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

AH Equity Partners LSV II's NAUT Position: Q3 2023 in Review

AH Equity Partners LSV II held its Nautilus Biotechnolgy (NAUT) position steady in Q3 2023 at 1,355,911 shares worth $4.28M. The position accounts for 4.48% of the portfolio, ranked #3.

AH Equity Partners LSV II first reported a position in NAUT in Q4 2021 and has held it in 8 quarters since. The position peaked at $5.88M in Q1 2022. 75 funds tracked by Wall St. Rank hold NAUT as of Q3 2023.

AH Equity Partners LSV II held 1,355,911 shares of Nautilus Biotechnolgy worth $4.28M as of Q3 2023.
AH Equity Partners LSV II left its Nautilus Biotechnolgy share count unchanged in Q3 2023.
Nautilus Biotechnolgy made up 4.48% of AH Equity Partners LSV II's portfolio in Q3 2023, its #3 holding.
AH Equity Partners LSV II first reported a position in Nautilus Biotechnolgy in Q4 2021 and has held it in 8 quarters since.
AH Equity Partners LSV II's Nautilus Biotechnolgy position peaked at $5.88M in Q1 2022.
75 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q3 2023.

Based on AH Equity Partners LSV II's 13F filing for Q3 2023, filed 14 Nov 2023.